Contraceptive Counseling for Gender Dysphoria
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve contraceptive counseling for transgender youth assigned female at birth by focusing on their experiences with the DMPA birth control shot. The study will gather insights through focus groups and interviews to help create better counseling practices. Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable form of birth control that has been the focus of recent research to improve accessibility and side-effect profiles.
Do I have to stop taking my current medications for this trial?
The trial information does not specify if you need to stop taking your current medications. It focuses on participants who are using or interested in using DMPA (a type of birth control shot).
Is contraceptive counseling for gender dysphoria safe?
There is limited data on the safety of contraceptive methods for transgender and gender-diverse people, especially when combined with gender-affirming hormone therapy. Providers often rely on data from cisgender women and clinical expertise to guide counseling, but specific safety information for this population is scarce.12345
How is the treatment 'Contraceptive Counseling for Gender Dysphoria' different from other treatments?
What data supports the effectiveness of the treatment for Contraceptive Counseling for Gender Dysphoria?
Gender-affirming hormone therapy, which is part of the treatment for gender dysphoria, has been shown to improve mental health and life satisfaction for those who need it. Hormone therapy helps align physical characteristics with gender identity, which can enhance quality of life and reduce psychological difficulties.411121314
Who Is on the Research Team?
Eva M Dindinger, MPH
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for transgender and gender diverse youth, assigned female at birth, aged 15-21, who are patients at certain clinics. It's for those currently using or interested in using the contraceptive Depo Medroxyprogesterone (DMPA). Those with health conditions that make DMPA unsafe based on CDC guidelines cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive instructions on home administration of DMPA SC and participate in focus groups and interviews
Follow-up
Participants are monitored for satisfaction with DMPA administration and counseling effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- Counseling
- Depo-subQ Provera Injectable Product
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor